Navigation Links
HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
Date:8/9/2012

FRAMINGHAM, Mass. and SYDNEY, Aug. 9, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference at 9:10 a.m. EDT on Tuesday, August 14, 2012.  The conference is being held August 14-15, 2012 at the Le Parker Meridien in New York City.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare has received CE Marking for the HeartWare System in the European Union and TGA approval in Australia.  The device is currently the subject of United States clinical trials for two indications: bridge-to-transplant and destination therapy.  For additional information, please visit www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HeartWare Reports Second Quarter 2012 Results
2. HeartWare Completes Acquisition Of World Heart Corporation
3. HeartWare Schedules Second Quarter Conference Call And Webcast
4. HeartWare Names Peter F. McAree Chief Financial Officer
5. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
6. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
7. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
8. Heartware Schedules First Quarter Conference Call And Webcast
9. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
10. Cepheid to Webcast Upcoming Financial Presentations
11. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Braeburn ... its current therapeutic focus beyond addiction and ... psychiatric disorders. Braeburn has acquired an implantable, ... antipsychotic risperidone for treatment of schizophrenia from ... acquires global rights to other potential applications ...
(Date:5/1/2015)... -- Pharmacyclics, Inc. (the "Company") (NASDAQ: PCYC ) ... 31, 2015, as well as general business updates. Due ... will be held. Key Highlights , ... increased to $206 million from $119 million for the ... ® (ibrutinib) net product revenue of $247 million ...
(Date:5/1/2015)... May 1, 2015  Misonix, Inc. (NASDAQ: ... designs, manufactures and markets innovative therapeutic ultrasonic products ... cosmetic surgery, laparoscopic surgery and other surgical applications, ... for the third quarter fiscal year 2015 on ... a conference call that same day, Thursday, May ...
Breaking Medicine Technology:Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 33
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that ... approvals necessary to complete the acquisition of Paddock ... of generic Rx pharmaceuticals and OTC specialty products. ... C. Papa stated, "We are looking forward to ...
... Corporation ("Unilife" or the "Company") (NASDAQ: UNIS ... completed the validation phase of the Unifill® ready-to-fill (prefilled) ... in the industrialization process for the Unifill syringe. ... completion of all validation tests associated with the Unifill ...
Cached Medicine Technology:Perrigo Provides Update on Acquisition of Paddock Labs 2Perrigo Provides Update on Acquisition of Paddock Labs 3Unilife Successfully Completes Industrialization of Unifill Syringe 2Unilife Successfully Completes Industrialization of Unifill Syringe 3Unilife Successfully Completes Industrialization of Unifill Syringe 4
(Date:5/1/2015)... Jusuru International has been awarded the ... of its flagship nutritional supplement, Liquid BioCell™ Life, and ... name, new logo, new packaging, new products, and new ... to identify and promote programs that serve as examples ... congratulates Jusuru International for their outstanding accomplishments and contributions ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 The ... leading nonprofit authority on the use of health IT ... a key contributing resource to the United States Government ... of electronically readable cards in Medicare. The report, “ ... Providers ” was released to the public on Apr. ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members in ... support for telemedicine. , “Such action is unprecedented ... Congress,” said Jonathan Linkous, CEO of the American Telemedicine Association ... to embrace the use of telecommunications in the delivery of ... mission to improve quality, access, equity and affordability of healthcare.”, ...
(Date:5/1/2015)... 2015 Ernst & Young (EY) has ... Co-Founder & CSO, and Burak Sezen, Co-Founder & CTO ... Entrepreneur Of The Year® 2015 Awards in the ... is a global leader in assurance, tax, transaction and ... of the top audit companies in the world. The ...
(Date:5/1/2015)... The Quail Creek Relay for Life Team ... 2001, the Quail Creek Relay team has raised almost $860,000. ... the year, including their biggest event, January’s Dinner and Auction; ... , Quail Creek Relay for Life team was established to ... fitness director, states, “I was hooked when I learned how ...
Breaking Medicine News(10 mins):Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2
... have evacuated more than 3,100 passengers from the Gulf Coast in ... Force Reserve and commercially-contracted flights. , ... (Vocus) September ... evacuated more than 3,100 passengers from the Gulf Coast in preparation ...
... and the Texas Ophthalmological, Association Remind Parents and the Public of ... Eyewear for Youth Sports and Back-to-School Leagues, AUSTIN, ... paintball smashed into his left eye and sent him from,the sidelines ... being very dizzy and I couldn,t stop vomiting," said Noah.,"I had ...
... LAS VEGAS, Aug. 31 , WHAT: Muscular Dystrophy Association National Chairman and ... use his Labor Day Telethon to encourage ... due to Gustav to seek out MDA services wherever they ... registered families in the affected areas., ...
... against the liver disease hepatitis C has been at ... 150 million people currently infected, and traditional antiviral treatments ... a cure. Using a novel technique, medical and engineering ... in the virus, reproduction process that in lab testing ...
... study led by Canadian researchers has found that telmisartan, ... outcome of cardiovascular death, heart attack or stroke in ... and effective standard treatment., Dr. Salim Yusuf and Dr. ... of Medicine at McMaster University and clinicians at Hamilton ...
... life of retinal cells that fight age-related macular ... Eating plenty of antioxidant-rich food such as blueberries, ... degeneration, the leading cause of age-related blindness in ... , U.S. researchers found that antioxidants disrupt a ...
Cached Medicine News:Health News:Air Force Hurricane Gustav Support 2Health News:Keep Eyes Safely On The Ball 2Health News:Keep Eyes Safely On The Ball 3Health News:New approach, old drug show promise against hepatitis C, Stanford research shows 2Health News:New approach, old drug show promise against hepatitis C, Stanford research shows 3Health News:Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke 2Health News:Antioxidant-Rich Diet May Protect Against Eye Disease 2
Used to negotiate spiral folds of the cystic duct and the lumen of the common duct. TFE coating reduces surface tension. Supplied sterile in peel-open packages. Intended for one-time use....
Used for common bile duct exploration. Supplied sterile in peel-open packages. Intended for one-time use....
... biopsy with the MAMMOTOME® HH ... minimally invasive procedure using ultrasound ... computer-generated images to locate breast ... pinpoint and map the area ...
... temporary wound support. Especially suitable for ... support material is desired and containment ... Predictable absorption. Polyglactin 910 has been ... nonpyrogenic. ,VICRYL (polyglactin 910) knitted mesh ...
Medicine Products: